BFSG »

Edgewise Therapeutics shares owned by BFSG

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by BFSG

Quarter filed Position value Share count Share price at filing
2024-09-30 $16k 600 26.69
2024-06-30 $11k 600 18.01

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Church & Dwight (CHD)
Raytheon Technologies Corp (RTX)
Vanguard World Energy Etf (VDE)
CSX Corporation (CSX)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Novo-nordisk A S Adr (NVO)

View all positions for BFSG

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics